Mogamulizumab versus vorinostat in previously treated...

  • Main
  • 2018 / 8
  • Mogamulizumab versus vorinostat in previously treated...
The Lancet Oncology 2018 / 8

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Kim, Youn H, Bagot, Martine, Pinter-Brown, Lauren, Rook, Alain H, Porcu, Pierluigi, Horwitz, Steven M, Whittaker, Sean, Tokura, Yoshiki, Vermeer, Maarten, Zinzani, Pier Luigi, Sokol, Lubomir, Morris,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30379-6
Date:
August, 2018
File:
PDF, 444 KB
english, 2018
Conversion to is in progress
Conversion to is failed